Agios Pharmaceuticals, Inc. (AGIO) stock prices updated...
 

Agios Pharmaceuticals, Inc. stock price

Agios Pharmaceuticals, Inc. latest news:


  • 02/15/2018 10:08:09

    BRIEF-Agios says FDA Accepts NDA And Grants Priority Review For Ivosidenib

    Agios Pharmaceuticals Inc(AGIO): * FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION. * FDA ACCEPTS NEW DRUG APPLICATION AND GRANTS PRIORITY REVIEW FOR IVOSIDENIB IN RELAPSED OR REFRACTORY AML WITH AN IDH1 MUTATION.

  • 01/18/2018 18:56:06

    BRIEF-Agios prices offering of 7.09 mln shares at $67 per share

    Agios Pharmaceuticals Inc(AGIO): * AGIOS ANNOUNCES PRICING OF $475 MILLION PUBLIC OFFERING OF COMMON STOCK. * AGIOS PHARMACEUTICALS(AGIO) - ‍IT HAS PRICED AN UNDERWRITTEN PUBLIC OFFERING OF 7.09 MILLION SHARES OF COMMON STOCK AT A PRICE TO PUBLIC OF $67.00 PER SHARE​ Source text for Eikon: Further company coverage:

  • 01/17/2018 14:08:18

    BRIEF-Agios Announces Proposed Offering Of Common Stock

    Agios Pharmaceuticals Inc(AGIO): * AGIOS ANNOUNCES PROPOSED OFFERING OF COMMON STOCK. * SAYS IT IS OFFERING TO SELL UP TO $400 MILLION OF ITS COMMON STOCK IN A PUBLIC OFFERING. * SAYS ALL OF SHARES IN OFFERING ARE TO BE SOLD BY AGIOS Source text for Eikon: Further company coverage:

  • 12/11/2017 14:01:18

    Promising responses seen with Agios leukemia drug in study

    Nearly a third of patients with an advanced form of a fast-progressing leukemia who carry a specific genetic mutation experienced a complete or near complete response to an experimental Agios Pharmaceuticals (AGIO) drug, according to data from an early stage trial released on Monday.

  • More trends:

    AgroFresh Solutions, Inc.AGFS | AgroFresh Solutions, Inc.AGFSW | Aimmune Therapeutics, Inc.AIMT | Air Methods CorporationAIRM | Air T, Inc.AIRT | Air Transport Services Group, IncATSG | AirMedia Group IncAMCN | Aixtron SEAIXG | Akamai Technologies, Inc.AKAM | Akebia Therapeutics, Inc.AKBA |